Radar mondial UDTR

UDTR — Radar mondial des droits de la Nature

Registre documentaire des références détectées à travers les infrastructures académiques, juridiques et institutionnelles surveillées par UDTR.

Une infrastructure documentaire mondiale conçue pour atteindre la couverture la plus large, vérifiable et scientifiquement défendable des droits de la Nature.

← Retour au Radar

Catalpol: An Iridoid Glycoside With Potential in Combating Cancer Development and Progression—A Comprehensive Review

Identification

Clé publique
radar:r-d3068517e09d7e98b1a6a4319a57ede1
Auteurs
Lucas Fornari Laurindo · Victória Dogani Rodrigues · Élen Landgraf Guiguer · Lívia Fornari Laurindo · Débora Aparecida Pires de Campos Zuccari · Cláudia Rucco Penteado Detregiachi · Adriano Cressoni Araújo · Jéssica da Silva Camarinha Oliveira · Durvanei Augusto Maria · Jefferson Aparecido Dias · Rose Elí Grassi Rici · Caroline Barbalho Lamas · Rosa Direito · Sandra Maria Barbalho
Année déclarée
2025
Langue déclarée
en
Type source
review
Première détection
2026-11-14T02:05:52.009710+00:00
Dernière observation des métadonnées
2026-11-14T02:05:52.009710+00:00
Dernière vérification HTTP
Non effectuée

Institutions déclarées par la source

Faculdade de Medicina de São José do Rio Preto · Universidade de Marília · Faculdade de Medicina de Marília · São Paulo State Technological College · Instituto Butantan · Universidade de São Paulo · Universidade Federal de São Carlos · University of Lisbon

Pays d’affiliation déclarés

BR · PT

Résumé documentaire — langue originale

Catalpol, a natural iridoid glycoside known for its anti-proliferative effects, has been proposed as an anticancer compound. Catalpol targets critical processes involved in cancer cell progression, like malignant proliferation, apoptosis, and metastasis. Additionally, catalpol presents potent anti-inflammatory and antioxidant properties crucial for cancer prevention and intervention. Due to the absence of clinical trials, this review investigates twelve studies, encompassing in vitro and animal trials from reputable databases, such as PubMed, with no time restrictions. Therefore, we covered evidence from catalpol's effects against several types of cancer, including breast, liver, colorectal, lung, gastric, bladder, and ovarian cancer, as well as osteosarcoma, and assessed various outcomes related to cell viability, apoptosis, migration, and modulation of molecular mechanisms by catalpol. Notably, catalpol induced cancer cell death via induction of mitochondrial apoptosis pathways, regulation of the expression of specific microRNAs, modulation of Sirt1, Kras, RACK1, PARP, PI3K/Akt, Bcl-2, and STAT3/JAK2/Src signaling pathways, and inactivation of NF-kB and Smad 2/3 signaling pathways. Furthermore, catalpol limits cancer metastasis due to modulation of critical metalloproteinases associated with cancer migration. Catalpol also synergizes with chemotherapeutic and adjuvant agents to induce cancer control, including regorafenib in liver cancer and chloroquine in gastric cancer, promoting increased anticancer action via upregulated cancer cell apoptosis, decreased proliferation, and inhibited angiogenesis via PI3K/p-Akt/mTOR/NF-κB, VEGF/VEGFR2, and Bax signaling pathways modulation. Catalpol derivatives also gained attention. Pyrazole-, imidazole-, and hydrolyzed-based catalpol derivatives increase cancer cell apoptosis and death and decrease tumor angiogenesis through similar pathways. This review seeks to provide understanding of catalpol's anticancer effects, its mechanisms of action, and its potential as a therapeutic anticancer agent while advocating for future research conductance.

Identifiants

OPENALEX
https://openalex.org/W4414434813
DOI
10.1002/ptr.70057
PMID
https://pubmed.ncbi.nlm.nih.gov/40985933
PMCID
https://www.ncbi.nlm.nih.gov/pmc/articles/12504809

Repères documentaires

Famille documentaire
unknown
Types déclarés par les sources
review
Éditeurs
Wiley

Les mentions d’entités ne constituent pas une preuve de reconnaissance juridique. La juridiction étudiée est distincte du pays d’affiliation des auteurs.

Sources

OpenAlex · Document 1

Citer cette référence

Lucas Fornari Laurindo; Victória Dogani Rodrigues; Élen Landgraf Guiguer; Lívia Fornari Laurindo; Débora Aparecida Pires de Campos Zuccari; Cláudia Rucco Penteado Detregiachi; Adriano Cressoni Araújo; Jéssica da Silva Camarinha Oliveira; Durvanei Augusto Maria; Jefferson Aparecido Dias; Rose Elí Grassi Rici; Caroline Barbalho Lamas; Rosa Direito; Sandra Maria Barbalho. Catalpol: An Iridoid Glycoside With Potential in Combating Cancer Development and Progression—A Comprehensive Review. 2025. https://doi.org/10.1002/ptr.70057

JSON · CSL-JSON · BibTeX · RIS · CSV · JSON-LD ·

APA, Chicago, ISO 690 : formats bibliographiques fondés sur les champs disponibles. OSCOLA / Bluebook : données structurées uniquement ; aucune conformité juridique complète n’est revendiquée sans vérification des éléments nécessaires.

APA
Lucas Fornari Laurindo; Victória Dogani Rodrigues; Élen Landgraf Guiguer; Lívia Fornari Laurindo; Débora Aparecida Pires de Campos Zuccari; Cláudia Rucco Penteado Detregiachi; Adriano Cressoni Araújo; Jéssica da Silva Camarinha Oliveira; Durvanei Augusto Maria; Jefferson Aparecido Dias; Rose Elí Grassi Rici; Caroline Barbalho Lamas; Rosa Direito; Sandra Maria Barbalho. (2025). Catalpol: An Iridoid Glycoside With Potential in Combating Cancer Development and Progression—A Comprehensive Review. https://doi.org/10.1002/ptr.70057
Chicago
Lucas Fornari Laurindo; Victória Dogani Rodrigues; Élen Landgraf Guiguer; Lívia Fornari Laurindo; Débora Aparecida Pires de Campos Zuccari; Cláudia Rucco Penteado Detregiachi; Adriano Cressoni Araújo; Jéssica da Silva Camarinha Oliveira; Durvanei Augusto Maria; Jefferson Aparecido Dias; Rose Elí Grassi Rici; Caroline Barbalho Lamas; Rosa Direito; Sandra Maria Barbalho. Catalpol: An Iridoid Glycoside With Potential in Combating Cancer Development and Progression—A Comprehensive Review. 2025. https://doi.org/10.1002/ptr.70057
ISO 690
Lucas Fornari Laurindo; Victória Dogani Rodrigues; Élen Landgraf Guiguer; Lívia Fornari Laurindo; Débora Aparecida Pires de Campos Zuccari; Cláudia Rucco Penteado Detregiachi; Adriano Cressoni Araújo; Jéssica da Silva Camarinha Oliveira; Durvanei Augusto Maria; Jefferson Aparecido Dias; Rose Elí Grassi Rici; Caroline Barbalho Lamas; Rosa Direito; Sandra Maria Barbalho. Catalpol: An Iridoid Glycoside With Potential in Combating Cancer Development and Progression—A Comprehensive Review. 2025. https://doi.org/10.1002/ptr.70057

Warning: Undefined array key "last_link_verified" in /home/clients/e27d81e12f04d2bfd747aa264540ac56/sites/_UDTR_APP/legal_library_reference.php on line 31

UDTR — Bibliothèque juridique mondiale des droits de la Nature. Catalpol: An Iridoid Glycoside With Potential in Combating Cancer Development and Progression—A Comprehensive Review. Notice documentaire: https://www.declarationuniverselledesdroitsdelarbre.org/global-rights-of-nature-radar/reference/r-d3068517e09d7e98b1a6a4319a57ede1/ · Dernière vérification HTTP : non effectuée

Signaler une correction

Données de cette version figée

Dossiers et relations documentaires

Rôles des sources

Source bibliographique / publication d’origine · https://doi.org/10.1002/ptr.70057

Un lien vers une autorité ne prouve pas à lui seul une affirmation juridique. Les résumés et les textes intégraux restent soumis aux conditions de leur source.

Statut documentaire

Pertinence à examiner

Bibliothèque

Cette identité n’est pas encore intégrée à la Bibliothèque juridique.

UDTR — Bibliothèque juridique mondiale des droits de la Nature